Diabetes Mellitus: prevención y riesgo de padecerla

OPS. La diabetes, un problema prioritario de salud pública en el Ecuador y la región de las Américas [Internet]. Eventos. 2020 [citado 10 de enero de 2022]. Disponible en: https://www3.paho.org/ecu/index.php?option=com_content&view=article&id=1400:la- diabetes-un-problema-prioritario-de-salud-publica-en-el-ecuador-y-la-region-de-las- americas&Itemid=360

OPS. Diabetes [Internet]. Temas. 2022 [citado 15 de febrero de 2022]. Disponible en: https://www.paho.org/es/temas/diabetes

Naciones Unidas CEPAL. La Agenda 2030 y los Objetivos de Desarrollo Sostenible Una oportunidad para América Latina y el Caribe Gracias por su interés en esta publicación de la CEPAL [Internet]. Publicación de las Naciones Unidas. 2018. 37-38 p. Disponible en: https://repositorio.cepal.org/bitstream/handle/11362/40155/24/S1801141_es.pdf

CEPAL. ODS 3 : Garantizar una vida sana y promover el bienestar para todos a todas las edades en América Latina y el Caribe 1 ODS 3 [Internet]. ODS. Objetivos de Desarrollo Sostenible. 2016. p. 1-4. Disponible en: https://www.cepal.org/sites/default/files/static/files/ods3_c1900667_press_2.pdf

MSP. Ministerio de Salud: prevención y autocuidado son claves para controlar la diabetes [Internet]. Noticias Destacadas. 2018 [citado 20 de enero de 2022]. Disponible en: https://www.salud.gob.ec/ministerio-de-salud-prevencion-y-autocuidado-son- claves-para-controlar-la-diabetes/

MSP, INEC, OPS/MSP. Encuesta STEPS Ecuador 2018 - Vigilancia de enfermedades no transmisibles y factores de riesgo. Minist Salud Publica [Internet]. 2018;1-66. Disponible en: https://www.salud.gob.ec/wp-content/uploads/2020/10/INFORME- STEPS.pdf

Constitución de la República del Ecuador [Internet]. 449 de 20-oct-2008 Ecuador: Registro Oficial; 2008. Disponible en: www.lexis.com.ec

Calderón Macías ML, Posada Vera EM. La formación doctoral e investigación científica en el área de la enfermería en Ecuador. Rev Eugenio Espejo [Internet]. 2022;16(1):90-7. Disponible en: http://scielo.senescyt.gob.ec/scielo.php?script=sci_arttext&pid=S2661- 67422022000100090

Ley 67. Ley Orgánica de Salud. Ley Órganica de Salud del Ecuador [Internet]. Ecuador; 2006 p. 32-3. Disponible en: https://www.salud.gob.ec/wp- content/uploads/2017/03/LEY-ORGÁNICA-DE-SALUD4.pdf

Ecuador CN de la R del. Registro Oficial No. 290. 2004-32 Ecuador; 2004 p. 3-5.

MSP. Estatuto Orgánico Sustitutivo de Gestión Organizacional por Procesos del Ministerio de Salud Pública. 4520 Ecuador: Acuerdo Ministerial; 2013 p. 168.

MSP. Acuerdo Ministerial 0002 - 2017. Ecuador: Ministerio de salud pública; 2017 p. 2.

MSP. Diabetes mellitus tipo 2. Guía de práctica clínica. 1a ed. Quito: Dirección Nacional de Normatización; 2017. 97 p.

M. ZMB. Prescripción del ejercicio en niños y adolescentes. Iatreia [Internet]. 21 de octubre de 2013 [citado 15 de octubre de 2022];26(4-S):S-19. Disponible en: https://revistas.udea.edu.co/index.php/iatreia/article/view/17132

OPS. Recomendaciones mundiales sobre actividad física para la salud [Internet]. Noticias. 2012 [citado 15 de agosto de 2022]. Disponible en: https://www.paho.org/es/noticias/9-5-2012-recomendaciones-mundiales-sobre- actividad-fisica-para-salud#:~:text=se recomienda que%3A-,1.,2.

Ecuador AN. Ley Orgánica de Comunicación [Internet]. 22 Ecuador: Registro Oficial; 2013 p. 24. Disponible en: https://www.arcotel.gob.ec/wp- content/uploads/downloads/2013/07/ley_organica_comunicacion.pdf

OPS E. El etiquetado tipo semáforo del Ecuador, una política pública que ha servido de ejemplo para otros países [Internet]. Noticias y Eventos. 2019 [citado 15 de septiembre de 2022]. Disponible en: https://www3.paho.org/ecu/index.php?option=com_content&view=article&id=2179:el- etiquetado-tipo-semaforo-del-ecuador-una-politica-publica-que-ha-servido-de-ejemplo- para-otros-paises&Itemid=360

MSP. Plan intersectorial de alimentación y nutrición 2018 - 2025 [Internet]. 0237-2018 Ecuador: Acuerdo Ministerial; 2018 p. 110. Disponible en: https://www.salud.gob.ec/wp-content/uploads/2018/08/PIANE-2018-2025-final- compressed-.pdf

Casanova JG, Casanova JMG, Ortiz FOM, Moreno M de la CC. Revista Universidad Médica Pinareña. Univ Médica Pinareña [Internet]. 2019;15(1):134-47. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=7079906

Campuzano-Maya G, Latorre-Sierra G. La HbA1c en el diagnóstico y en el manejo de la diabetes. Medicina & Laboratorio. Med Lab [Internet]. 2010;16:211-41. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=32246

Kojdamanian Favetto V. Guía NICE 2022: actualización en el manejo de la diabetes mellitus tipo 2 en personas adultas. Evidencia, Actual en la práctica ambulatoria [Internet]. 2022;25(2):e007015. Disponible en:

https://www.evidencia.org/index.php/Evidencia/article/view/7015/4697

American Diabetes Association Professional Practice Conmitte. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(January):S244-53.

Diabetes Teaching Center at the University of California. Metformin [Internet]. Type 2 Non Insulin Therapies. 2022 [citado 20 de agosto de 2022]. Disponible en: https://dtc.ucsf.edu/types-of-diabetes/type2/treatment-of-type-2-diabetes/medications- and-therapies/type-2-non-insulin-therapies/metformin/

Harper W, Clement M, Goldenberg R, Hanna A, Main A, Retnakaran R, et al. Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes- 2015 Interim Update. Can J Diabetes [Internet]. 2015;39(4):250-2. Disponible en: http://dx.doi.org/10.1016/j.jcjd.2015.05.009

Cahn A, Cefalu WT. Clinical considerations for use of initial combination therapy in type 2 diabetes. Diabetes Care. 2016;39(August):S137-45.

Phung OJ, Sobieraj DM, Engel SS, Rajpathak SN. Early combination therapy for the treatment of type 2 diabetes mellitus: Systematic review and meta-analysis. Diabetes, Obes Metab. 2014;16(5):410-7.

U.S. Food & Drug Administration. La FDA advierte que el uso de inhibidores de la DPP- 4 para la diabetes de tipo 2 puede causar dolor articular intenso [Internet]. Drug Safety and Avaliability. 2015 [citado 10 de agosto de 2022]. Disponible en: https://www.fda.gov/drugs/drug-safety-and-availability/la-fda-advierte-que-el-uso-de- inhibidores-de-la-dpp-4-para-la-diabetes-de-tipo-2-puede-causar-dolor

Yap-Campos K, Sánchez-Gálvez X, Rivero-López CA. El papel de los inhibidores de la dPP4: un enfoque actual en el manejo de la diabetes mellitus tipo 2. Atención Fam [Internet]. 2017;24(3):136-9. Disponible en: https://www.medigraphic.com/cgi- bin/new/resumen.cgi?IDARTICULO=73036

Nicolle LE, Capuano G, Ways K, Usiskin K. Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study. Curr Med Res Opin [Internet]. 2012;28(7):1167-71. Disponible en: https://www.tandfonline.com/doi/full/10.1185/03007995.2012.689956?scroll=top&nee dAccess=true

Wilding JPH, Woo V, Soler NG, Pahor AP, Sugg J, Rohwedder K, et al. Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses

of insulin a randomized trial. Ann Intern Med. 2012;156(6):405-15.

Rosas-Guzman J, Rosas-Saucedo J, Romero-García RJ, Romero-García A. SGLT2 Inhibitors in Diabetes Mellitus Treatment. Rev Recent Clin Trials [Internet]. 2017;12(1):8-18. Disponible en: https://www.ingentaconnect.com/content/ben/rrct/2017/00000012/00000001/art00005# expand/collapse

Ramos Sánchez A. Primer agonista GLP-1 de administración oral. MPG J [Internet]. 2019;2(46):4-5. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8636867

Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care. 2010;33(12).

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(SUPPL.1):81-90.

Centro de Medicina fetal i Neonatal de Barcelona. Diabetes gestacional [Internet]. Vol.

Barcelona; 2018. Disponible en: https://medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/diabetes gestacional.pdf

Asociación Latinoamericana de Diabetes. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia Edición 2019 ALAD. Rev la Asoc Latinoam Diabetes. 2019;125.

Simó R, Plana-Ripoll O, Puente D, Morros R, Mundet X, Vilca LM, et al. Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study. PLoS One. 2013;8(11).

Agencia Europea de Medicamentos y Productos Sanitarios. Anexo I: Ficha técnica o resumen de las características del producto 1 [Internet]. CIMA. 2020. p. 1-33. Disponible en: https://www.ema.europa.eu/en/documents/product-information/kyntheum-epar- product-information_es.pdf

López Anaya L, Lobo Guerrero JA, Yanes Peña W. Epidemiología de la diabetes mellitus. Rev la Fac Ciencias Salud [Internet]. 2005;2(2):143-6. Disponible en: https://revistas.unimagdalena.edu.co/index.php/duazary/article/view/297/264

Arango Santillán DL. Factores que intervienen en la adherencia al tratamiento farmacológico de Hipertensión Arterial y Diabetes en los Adultos Mayores del Centro de Salud Imbaya de Atuntaqui 2021. Universidad Técnica del Norte; 2021.

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol [Internet]. 2018;14(2):88-98. Disponible en: http://dx.doi.org/10.1038/nrendo.2017.151

Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019;8(3):R55-70.

Massey CN, Feig EH, Duque-Serrano L, Wexler D, Moskowitz JT, Huffman JC. Well- being interventions for individuals with diabetes: A systematic review. Diabetes Res Clin Pract [Internet]. 2019;147:118-33. Disponible en: https://doi.org/10.1016/j.diabres.2018.11.014

National Library of Medicine. Preventing type 2 diabetes [Internet]. InformedHealth.org. 2006. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK361018/

Conget DI. Diagnosis, classification and pathogenesis of diabetes mellitus. Rev Esp Cardiol [Internet]. 2002;55(5):528-35. Disponible en: http://dx.doi.org/10.1016/S0300- 8932(02)76646-3

Care D, Suppl SS. Prevention or delay of type 2 diabetes: Standards of medical care in Diabetesd2018. Diabetes Care. 2018;41(January):S51-4.

Osama AJ, Shehab AEK. Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients. Afr Health Sci. 2015;15(2):503- 12.

Howley ET. Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sport Exerc. 2001;33(6):364-9.

Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59.

Qaisar R, Bhaskaran S, Van Remmen H. Muscle fiber type diversification during exercise and regeneration. Free Radic Biol Med [Internet]. 2016;98:56-67. Disponible en: http://dx.doi.org/10.1016/j.freeradbiomed.2016.03.025

Soares FHR, de Sousa MBC. Different Types of Physical Activity on Inflammatory Biomarkers in Women With or Without Metabolic Disorders: A Systematic Review. Women Heal. 2013;53(3):298-316.

De Sousa RAL. Brief report of the effects of the aerobic, resistance, and high-intensity interval training in type 2 diabetes mellitus individuals. Int J Diabetes Dev Ctries.

;38(2):138-45.

De Sousa RAL, Improta-Caria AC, Jesus-Silva FM de, Magalhães COD e., Freitas DA, Lacerda ACR, et al. High-intensity resistance training induces changes in cognitive function, but not in locomotor activity or anxious behavior in rats induced to type 2 diabetes. Physiol Behav [Internet]. 2020;223(June):112998. Disponible en: https://doi.org/10.1016/j.physbeh.2020.112998

Botta A, Laher I, Beam J, DeCoffe D, Brown K, Halder S, et al. Short Term Exercise Induces PGC-1α, Ameliorates Inflammation and Increases Mitochondrial Membrane Proteins but Fails to Increase Respiratory Enzymes in Aging Diabetic Hearts. PLoS One. 2013;8(8).

Lourenco M V., Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med [Internet]. 2019;25(1):165-75. Disponible en: http://dx.doi.org/10.1038/s41591-018-0275-4

George EK, Hemachandra Reddy P. Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals? J Alzheimer’s Dis. 2019;72(s1):S37-58.

Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34(39):3035-87.

Mendes R, Sousa N, Almeida A, Subtil P, Guedes-Marques F, Reis VM, et al. Exercise prescription for patients with type 2 diabetes - A synthesis of international recommendations: Narrative review. Br J Sports Med. 2016;50(22):1379-81.

Hansen D, Peeters S, Zwaenepoel B, Verleyen D, Wittebrood C, Timmerman N, et al. Exercise assessment and prescription in patients with type 2 diabetes in the private and home care setting: Clinical recommendations from AXXON (Belgian Physical Therapy Association). Phys Ther. 2013;93(5):597-610.

Cai H, Li G, Zhang P, Xu D, Chen L. Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review. Qual Life Res. 2017;26(3):515-30.

Blair SN, Iii HWK, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. Physical Fitness and All-Cause Mortality. 2015;

Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood E. Exercise capacity and mortality among men referred for excercise testing. New Engl. 2002;346(11):793-801.

Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases.

Compr Physiol. 2012;2(2):1143-211.

Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women. J Am Med Assoc. 2009;301(19):2024-35.

Koch LG, Kemi OJ, Qi N, Leng SX, Bijma P, Gilligan LJ, et al. Intrinsic aerobic capacity sets a divide for aging and longevity. Circ Res. 2011;109(10):1162-72.

Timmons JA, Knudsen S, Rankinen T, Koch LG, Sarzynski M, Jensen T, et al. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol. 2010;108(6):1487-96.

Keller P, Vollaard NBJ, Gustafsson T, Gallagher IJ, Sundberg CJ, Rankinen T, et al. A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol. 2011;110(1):46-59.

Ross A, Bevans M, Brooks AT, Gibbons S, Wallen GR. Nurses and Health-Promoting Behaviors: Knowledge May Not Translate Into Self-Care. AORN J [Internet]. 2017;105(3):267-75. Disponible en: http://dx.doi.org/10.1016/j.aorn.2016.12.018

Slentz CA, Tanner CJ, Bateman LA, Durheim MT, Huffman KM, Houmard JA, et al. Effects of Exercise Training Intensity on Pancreatic Cell Function. Clin Care. 2009;32(10):1807-11.

Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U, et al. Global physical activity levels: Surveillance progress, pitfalls, and prospects. Lancet [Internet]. 2012;380(9838):247-57. Disponible en: http://dx.doi.org/10.1016/S0140- 6736(12)60646-1

Bacon AP, Carter RE, Ogle EA, Joyner MJ. VO2max Trainability and High Intensity Interval Training in Humans: A Meta-Analysis. PLoS One. 2013;8(9).

Sarzynski MA, Ghosh S, Bouchard C. Genomic and transcriptomic predictors of response levels to endurance exercise training. J Physiol. 2017;595(9):2931-9.

Schneider J. Age dependency of oxygen uptake and related parameters in exercise testing: An expert opinion on reference values suitable for adults. Lung. 2013;191(5):449-58.

Toedebusch RG, Ruegsegger GN, Braselton JF, Heese AJ, Hofheins JC, Childs TE, et al. AMPK agonist AICAR delays the initial decline in lifetime-apex Vo2peak, while voluntary wheel running fails to delay its initial decline in female rats. Physiol Genomics. 2016;48(2):101-15.

Ruegsegger GN, Toedebusch RG, Braselton JF, Childs TE, Booth FW. Left ventricle

transcriptomic analysis reveals connective tissue accumulation associates with initial age-dependent decline in V˙o2peakfrom its lifetime apex. Physiol Genomics. 2017;49(1):53-66.

Schuch FB, Vancampfort D, Sui X, Rosenbaum S, Firth J, Richards J, et al. Are lower levels of cardiorespiratory fitness associated with incident depression? A systematic review of prospective cohort studies. Prev Med (Baltim) [Internet]. 2016;93:159-65. Disponible en: http://dx.doi.org/10.1016/j.ypmed.2016.10.011

Owen N. Sedentary behavior: Understanding and influencing adults’ prolonged sitting time. Prev Med (Baltim) [Internet]. 2012;55(6):535-9. Disponible en: http://dx.doi.org/10.1016/j.ypmed.2012.08.024

Healy GN, Dunstan DW, Salmon J, Shaw JE, Zimmet PZ, Owen N. Television time and continuous metabolic risk in physically active adults. Med Sci Sports Exerc. 2008;40(4):639-45.

Sugiyama T, Ding D, Owen N. Commuting by car: Weight gain among physically active adults. Am J Prev Med. 2013;44(2):169-73.

Ng SW, Popkin BM. Time use and physical activity: A shift away from movement across the globe. Obes Rev. 2012;13(8):659-80.

Koohsari MJ, Sugiyama T, Sahlqvist S, Mavoa S, Hadgraft N, Owen N. Neighborhood environmental attributes and adults’ sedentary behaviors: Review and research agenda. Prev Med (Baltim) [Internet]. 2015;77:141-9. Disponible en: http://dx.doi.org/10.1016/j.ypmed.2015.05.027

Chavarrias M, Carlos-Vivas J, Collado-Mateo D, Pérez-Gómez J. Health benefits of indoor cycling: A systematic review. Med. 2019;55(8):1-14.

Pedersen BK, Stalin B. Evidence for prescribing exercise as therapy in chronic disease. Scand Med Sci Sport. 2006;16(1):3-63.

Caria MA, Tangianu F, Concu A, Crisafulli A, Mameli O. Quantification of Spinning® bike performance during a standard 50-minute class. J Sports Sci. 2007;25(4):421-9.

Battista RA, Foster C, Andrew J, Wrihgt G, Lucia A, Porcari J. Phisiologic responses during indoor cycling. J Strength Cond Res. 2008;22(4):1236-41.

Srinivasan J, Balasubramanian V. Effect of LBP on muscle activity of lower back and upper extremity while aerobic cycling - An sEMG based study. En: ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering. 2006. p. 414-7.

Hedman K, Bjarnegård N, Länne T. Left Ventricular Adaptation to 12 Weeks of Indoor

Cycling at the Gym in Untrained Females. Int J Sports Med. 2017;38(9):653-8.

Hamer M, Chida Y. Active commuting and cardiovascular risk : A meta-analytic review. 2008;46:9-13.

Woodcock J, Edwards P, Tonne C, Armstrong BG, Ashiru O, Banister D, et al. Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport. Lancet [Internet]. 2009;374(9705):1930-43. Disponible en: http://dx.doi.org/10.1016/S0140-6736(09)61714-1

Rasmussen MG, Grøntved A, Blond K, Overvad K, Tjønneland A, Jensen MK, et al. Associations between Recreational and Commuter Cycling, Changes in Cycling, and Type 2 Diabetes Risk: A Cohort Study of Danish Men and Women. PLoS Med. 2016;13(7):1-17.

Sahlqvist S, Goodman A, Simmons RK, Khaw KT, Cavill N, Foster C, et al. The association of cycling with all-cause, cardiovascular and cancer mortality: Findings from the Population-based EPIC-Norfolk cohort. BMJ Open. 2013;3(11).

Stewart G, Anokye NK, Pokhrel S. What interventions increase commuter cycling? A systematic review. BMJ Open. 2015;5(8):1-10.

Yang L, Sahlqvist S, McMinn A, J Griffin S, Ogilvie D. Interventions to promote cycling: systematic review. BMJ. 2010;341:870.

Sallis JF, Cerin E, Conway TL, Adams MA, Frank LD, Pratt M, et al. Physical activity in relation to urban environments in 14 cities worldwide: A cross-sectional study. Lancet. 2016;387(10034):2207-17.

Craig P, Cooper C, Gunnell D, Haw S, Lawson K, Macintyre S, et al. Using natural experiments to evaluate population health interventions: New medical research council guidance. J Epidemiol Community Health. 2012;66(12):1182-6.

Ogilvie D, Egan M, Hamilton V, Petticrew M. Systematic reviews of health effects of social interventions: 2. Best available evidence: How low should you go? J Epidemiol Community Health. 2005;59(10):886-92.

Kessler R, Glasgow RE. A proposal to speed translation of healthcare research into practice: Dramatic change is needed. Am J Prev Med [Internet]. 2011;40(6):637-44. Disponible en: http://dx.doi.org/10.1016/j.amepre.2011.02.023

Reis RS, Salvo D, Ogilvie D, Lambert E V., Goenka S, Brownson RC. Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving. Lancet [Internet]. 2016;388(10051):1337-48. Disponible en: http://dx.doi.org/10.1016/S0140-6736(16)30728-0

Organización Mundial de la Salud. Diabetes [Internet]. Detalle. 2022 [citado 20 de septiembre de 2022]. Disponible en: https://www.who.int/es/news-room/fact- sheets/detail/diabetes

Organización Mundial de la Salud. Informe mundial sobre la diabetes [Internet]. Vol. 3, Informe Mundial Sobre La Diabetes. 2020. Disponible en: www.who.int

National Institute of Diabetes and Digestive and Kidney Diseases. Factores de riesgo para la diabetes tipo 2 [Internet]. Información general sobre la diabetes. 2016 [citado 20 de septiembre de 2022]. Disponible en: https://www.niddk.nih.gov/health- information/informacion-de-la-salud/diabetes/informacion-general/factores-riesgo-tipo- 2

Rojas de P, Elizabeth; Molina, Rusty ; Rodríguez C. Definición, Clasificación Y Diagnóstico De La Diabetes Mellitus. Defin Clasif Y Diagnóstico La Diabetes Mellit. 2012;7-12.

Palacio Rojas M, Bermúdez V, Hernández Lalinde J, Ajila Vacacela J, Peñaloza Buele Y, Aguirre Carrión C, et al. Comportamiento epidemiológico de la diabetes mellitus tipo 2 y sus factores de riesgo en pacientes adultos en la consulta externa del Hospital Básico de Paute, Azuay - Ecuador. Rev Latinoam Hipertens. 2018;13(2):89-96.

Ferraro M, Jimenez V, Strasnoy I, Taberner P, Mc M. Criterios diagnósticos, clínicos y de laboratorio de la Diabetes Mellitus. Curso Int Niños y Jóvenes con Diabetes [Internet]. 2008;127-9. Disponible en: https://www.revistaalad.com/pdfs/0904_CriteriosD.pdf

Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes [Internet]. 2018;42:S10-

Disponible en: https://doi.org/10.1016/j.jcjd.2017.10.003

Metzger BE. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-82.

Gómez Candela C, Milla Palma S. Nutrición y diabetes. En: Exlibris Ediciones SL, editor. Manual Práctico de Nutrición y Salud. Primera. Alcobendas; 2012. p. 295-310.

Durán Agüero S, Carrasco Piña E, Araya Pérez M. Alimentación y diabetes. Nutr Hosp. 2012;27(4):1031-6.

Castro R. ¿Es el índice glucémico útil para controlar la glucemia si tienes diabetes? [Internet]. Información sobre salud. 2022 [citado 10 de agosto de 2022]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/diabetes/expert- answers/diabetes/faq-20058466#:~:text=El índice glucémico clasifica los,alimentos con

un valor menor.

Murillo S. El índice glucémico de los alimentos [Internet]. La diabetes. 2012 [citado 20 de julio de 2022]. Disponible en: https://www.fundaciondiabetes.org/general/articulo/47/el-indice-glucemico-de-los- alimentos

Manuzza, Brito, Echegaray L. Índice glucémico y carga glucémica: su valor en el tratamiento y la prevención de las enfermedades crónicas no transmisibles TT - Glycemic index and glycemic load: their value in treatment and prevention of noncommunicable chronic diseases. Diaeta (B Aires) [Internet]. 2018;36(162):35. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1852- 73372018000100005&lng=es&nrm=iso&tlng=es

Berrones JGA, Paredes KAC, Cevallos MDLÁR. Nutritional intervention in older adults with type 2 diabetes mellitus to achieve glycemic control. Rev Cuba Med Mil. 2020;49(3):1-19.

Riobó P. Pautas dietéticas en la diabetes y en la obesidad. Nutr Hosp [Internet]. 2018;35(4):109-15. Disponible en: http://revista.nutricionhospitalaria.net/index.php/nh/article/view/2135

Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparasion of a high- carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin- dependent diabetes mellitus. N Engl J Med. 2010;319(13):829-34.

Vilaplana M. Farmacia Abierta Nutrición y diabetes. Farm Prof. 2015;29(2):26–30.

RedGDPS. Alimentación en el paciente con diabetes tipo 2. Vol. 2, Guía de diabetes tipo 2 para clínicos. 2018. p. 43-9.

Sanz Vela N. Los cambios en el estilo de vida: el primer escalón en la prevención y el tratamiento de la diabetes mellitus. Diabetes Práctica. 2021;12(01):1-34.

Pelaz-Berdullas L, Calle-Pascual AL. Protein diet in type 2 diabetes. No. Av en Diabetol [Internet]. 2012;28(1):27-31. Disponible en: http://dx.doi.org/10.1016/j.avdiab.2011.11.001

Socarrás Suárez MM, Bolet Astoviza M, Licea Puig M. Diabetes mellitus: tratamiento dietético. Rev Cuba Investig Biomédicas [Internet]. 2002 [citado 12 de diciembre de 2022];21(2):102-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 03002002000200007&lng=es&nrm=iso&tlng=en

American Diabetes Association. Nutrition Recommendations and Interventions for

Diabetes-2006. Diabetes Care [Internet]. 2006;29(9):2140-57. Disponible en: http://dx.doi.org/10.1016/j.jaci.2012.05.050

Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, et al. Effects of bilio-pancreatic diversion on diabetic complications: A 10-year follow-up. Diabetes Care. 2011;34(3):561-7.

Milech A. Diretrizes da Sociedade Brasileira de Diabetes (2015-2016). Paulo de Oliveira J, Vencio S, editores. Sao Paulo: A.C. Farmacéutica; 2016. 348 p.

Rabbani N, Thornalley PJ, Transporters T. Emerging role of thiamine therapy for prevention and treatment of early-stage Diabetic Nephropathy. Obe Metab. 2011;577- 83.

Schlickmann D da S, Molz P, Pereira CS, Franke SIR. Evaluación del consumo de macronutrientes y micronutrientes por individuos prediabéticos. Cad Saúde Coletiva. 2022;30(2):189-200.

Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, et al. Status of B-Vitamins and homocysteine in diabetic retinopathy: Association with Vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One. 2011;6(11).

Mazloom Z, Ekramzadeh M, Hejazi N. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: A randomized, single-blind, placebo-controlled trial. Pakistan J Biol Sci. 2013;16(22):1597-600.

Montero D, Walther G, Stehouwer CDA, Houben AJHM, Beckman JA, Vinet A. Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014;15(2):107-16.

Thomas GN, Hartaigh BÓ, Bosch JA, Pilz S, Loerbroks A, Kleber ME, et al. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: The Ludwigshafen risk and cardiovascular health (LURIC) study. Diabetes Care. 2012;35(5):1158-64.

Kim H-J, Kang C-K, Park H, Lee M-G. Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women. J Exerc Nutr Biochem. 2014;18(3):249-57.

McNall AD, Etherton TeD, Fosmire GJ. The Impaired Growth Induced by Zinc Deficiency in Rats Is Associated with Decreased Expression of the Hepatic Insulin-like Growth Factor I and Growth Hormone Receptor Genes. J Nutr. 1995;125(4):874-9.

De Los Ángeles Granados-Silvestre M, Ortiz-López MG, Montúfar-Robles I, Menjívar-

Iraheta M. Micronutrientes y diabetes, el caso de los minerales. Cir Cir. 2014;82(1):119- 25.

Arquilla ER, Packer S, Tarmas W, Miyamoto S. The effect of zinc on insulin metabolism. Endocrinology. 1978;103(4):1440-9.

Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006;29(8):1826-32.

Wälti MK, Zimmermann MB, Walczyk T, Spinas GA, Hurrell RF. Measurement of magnesium absorption and retention in type 2 diabetic patients with the use of stable isotopes. Am J Clin Nutr. 2003;78(3):448-53.

Drake EN. Cancer chemoprevention: Selenium as a prooxidant, not an antioxidant. Med Hypotheses. 2006;67(2):318-22.

Siddiqui K, Bawazeer N, Scaria Joy S. Variation in macro and trace elements in progression of type 2 diabetes. Sci World J. 2014;2014(Figure 1).

Dongiovanni P, Valenti L, Fracanzani AL, Gatti S, Cairo G, Fargion S. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol [Internet]. 2008;172(3):738-47. Disponible en: http://dx.doi.org/10.2353/ajpath.2008.070097

Gong R, Wang P, Dworkin L. What we need to know about the effect of lithium on the kidney. Am J Physiol - Ren Physiol. 2016;311(6):F1168-71.

McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C. A.S.P.E.N. clinical guidelines: Nutrition support of adult patients with hyperglycemia. J Parenter Enter Nutr. 2013;37(1):23-36.

OMS. Prevención de la Diabetes Mellitus. En: Organización Mundial de la Salud, editor. Serie de Informes Técnicos. Ginebra; 1994. p. 140.

Mediavilla Bravo JJ. Complicaciones de la diabetes mellitus. Diagnóstico y tratamiento. Semergen. 2001;27:132-45